News and Trends 30 Nov 2022
TrialSpark acquires immunodermatology portfolio and creates Libertas Bio
…novel therapies. TrialSpark is focused on clinical stage assets in rheumatology, dermatology, CNS, and cardiometabolic diseases, with a focus on chronic diseases that are treated outside of a hospital setting….